BioCentury
ARTICLE | Company News

PhotoBiotics deal

December 13, 2010 8:00 AM UTC

PhotoBiotics partnered with an undisclosed pharma to use PhotoBiotics' OptiLink antibody-drug conjugation (ADC) technology in a new indication. The platform uses small antibody fragments (scFvs) with ...